Genomic survey of Clostridium difficile reservoirs in the East of England implicates environmental contamination of wastewater treatment plants by clinical lineages. by Moradigaravand, Danesh et al.
Downloaded from www.microbiologyresearch.org by
IP:  131.111.184.102
On: Tue, 22 May 2018 11:27:34
Genomic survey of Clostridium difficile reservoirs in the East of
England implicates environmental contamination of wastewater
treatment plants by clinical lineages
Danesh Moradigaravand,1,* Theodore Gouliouris,2 Catherine Ludden,3 Sandra Reuter,4 Dorota Jamrozy,1 Beth Blane,2
Plamena Naydenova,2 Kim Judge,1 Sani H. Aliyu,2 Nazreen F. Hadjirin,2 Mark A. Holmes,2 Estee Török,2
Nicholas M. Brown,2 Julian Parkhill1 and Sharon Peacock2
Abstract
There is growing evidence that patients with Clostridiumdifficile-associated diarrhoea often acquire their infecting strain
before hospital admission. Wastewater is known to be a potential source of surface water that is contaminated with
C. difficile spores. Here, we describe a study that used genome sequencing to compare C. difficile isolated from multiple
wastewater treatment plants across the East of England and from patients with clinical disease at a major hospital in the
same region. We confirmed that C. difficile from 65 patients were highly diverse and that most cases were not linked to other
active cases in the hospital. In total, 186 C. difficile isolates were isolated from effluent water obtained from 18 municipal
treatment plants at the point of release into the environment. Whole genome comparisons of clinical and environmental
isolates demonstrated highly related populations, and confirmed extensive release of toxigenic C. difficile into surface waters.
An analysis based on multilocus sequence types (STs) identified 19 distinct STs in the clinical collection and 38 STs in the
wastewater collection, with 13 of 44 STs common to both clinical and wastewater collections. Furthermore, we identified five
pairs of highly similar isolates (2SNPs different in the core genome) in clinical and wastewater collections. Strategies to
control community acquisition should consider the need for bacterial control of treated wastewater.
DATA SUMMARY
Sequence data deposited in the European Nucleotide Archive
(ENA) (www.ebi.ac.uk/ena) under the individual accession
numbers, along with the metadata of each isolate, are
described in Table S1 (available in the online version of this
article). There were restrictions on providing exact geographi-
cal locations of wastewater treatment plants. We confirm that
all supporting data, code and protocols have been provided
within the article or through supplementary data files.
INTRODUCTION
Clostridium difficile is a major cause of healthcare-associ-
ated infection worldwide [1–6]. Infection has been linked to
nosocomial acquisition and epidemic spread of C. difficile
[7], which has led to extensive hospital infection control
measures combined with antimicrobial stewardship [8]. In
the UK, there has been a major decline in incidence
associated with a dramatic reduction in fluoroquinolone-
resistant epidemic strains such as the hypervirulent ST1/
ribotype 027 (027) [9]. In parallel with this has been a shift
towards increasing community-acquired disease, which
accounts for about one-third of cases and an increase in
C. difficile ribotype diversity [10]. Recent studies in the UK
employing whole genome sequencing have found that less
than half of isolates causing C. difficile infection are geneti-
cally linked to isolates from active cases [11, 12].
Taken together, these observations suggest that patients
with C. difficile-associated diarrhoea increasingly acquire
their infecting strain prior to hospital admission. These
marked changes in clinical and bacterial epidemiology
necessitate consideration of alternative reservoirs for C. dif-
ficile [13–17]. Wastewater treatment plants have been pro-
posed as potential reservoirs for C. difficile, and C. difficile
ribotypes associated with clinical disease have been isolated
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previously from such sources [18–20], but surveillance of
wastewater treatment plants and clinical reservoirs in the
same geographical region using whole genome sequencing
is lacking. Here, we investigate C. difficile in multiple waste-
water treatment plants across the East of England, half of
which were located downstream of hospitals, and compare
these to clinical isolates from the same geographical region
but sampled in a different time interval.
METHODS
Isolates from patients with C. difficile-associated
diarrhoea
A retrospective study was performed at the Cambridge Uni-
versity Hospitals NHS Foundation Trust between October
2012 and April 2013. Stool samples were processed at the
on-site Public Health England Clinical Microbiology and
Public Health Laboratory. Samples were tested using a com-
mercial assay (C. DIFF QUIK CHEK COMPLETE; Techlab),
which detects glutamate dehydrogenase (GDH) antigen and
toxins A and B of C. difficile. Positive samples were cultured
anaerobically for 48 h onto Brazier’s cycloserine-cefoxitin-
egg yolk (CCEY) agar (BioConnections) using alcohol shock
(https://www.gov.uk/government/publications/smi-b-10-
processing-of-faeces-for-clostridium-difficile) and colonies
with typical appearance were identified by MALDI-TOF
MS (Biotyper version 3.1; Bruker Daltonics). Stool samples
from which C. difficile was isolated were stored at  80

C
prior to repeated recovery of C. difficile, DNA extraction
and sequencing. Clinical data were recorded on patient age,
gender, date of hospital admission, discharge and ward
movement, and previous admission to hospital in the pre-
ceding 6 months. Recurrent C. difficile infection was defined
as the onset of diarrhoea 4 weeks or more after the end of
the prior episode.
Isolation of C. difficile from wastewater treatment
plants
A cross-sectional study was performed in which 20 munici-
pal wastewater treatment plants were sampled in the East of
England between June 2014 and January 2015. Ten plants
were situated immediately downstream of acute NHS Hos-
pital Trusts and ten plants were not connected to acute hos-
pital effluent. Paired samples of untreated (at inlet after
initial screening to remove large solids but prior to reaching
the primary settlement tanks) and treated (effluent at the
point of release) wastewater were obtained from each plant.
The main septic tank at the Cambridge University Hospitals
NHS Foundation Trust was also sampled in September
2014. At each wastewater sampling point, two consecutive
grab samples of 0.5 litres each were collected and mixed
into 1 litre sterile bottles containing 18mg sodium thiosul-
phate (Sigma-Aldrich). Triplicate neat [1, 10 and 100ml
(the last only for treated)] and dilutions of untreted (1ml of
10 1 and 10 2) and treated (1ml of 10 1) wastewater sam-
ples were concentrated using the filtration technique onto
0.45 µm pore size, mixed cellulose ester filter membranes
(S-Pak; Merck Millipore). For wastewater plants 12–20, an
alcohol shock step was additionally used on 1 and 10ml
neat samples (addition of 1 : 1 volume of 100% ethanol for
30min) prior to filtration to remove false-positive anaerobic
vegetative growth. Membranes were placed aseptically onto
chromID C. difficile selective plates (bioMerieux) and
incubated anaerobically for 48 h at 37

C. Multiple colonies
with morphology consistent with C. difficile were picked
from each positive plate and identified to species level by
MALDI-TOF MS.
DNA sequencing, genome assembly and population
genomics analyses
DNA libraries were prepared according to the Illumina pro-
tocol and sequenced on an Illumina HiSeq2000 device with
100-cycle paired-end runs to give an average depth of 85-
fold. Taxonomic identity was assigned to all short reads and
assemblies using Kraken [21]. Multilocus sequence types
(STs) were derived from Illumina read data using an in-
house tool, available at https://github.com/sanger-patho-
gens/mlst_check. De novo multi-contig draft assemblies
were produced using an improved algorithm based on Vel-
vet [22]. The assembly pipeline gave an average total length
of 4 216 955 bp (range 3 839 400–5 306 342) from 45 contigs
(range 22–1866) with an average contig length of 119 057 bp
(range 2843–187 572 bp) and an average N50, which is a sta-
tistic measured such that at least half of the nucleotides in
the assembly belongs to contigs with the length equal to or
longer than the statistic, of 432337.9 (range 140 791–
841 201). The de novo assemblies were annotated using
Prokka [23], and these were then used in the pan-genome
analysis using Roary [24]. A cut-off of 95% was used to
define the locus match in the pan-genome analysis. Scoary
[25], with 50 permutation tests for the empirical P-value,
was used to identify accessory genes in isolates from waste-
water versus clinical origin. After reconstruction of the core
genome alignment, SNPs in the core genome were extracted
using an in-house tool, available at www.github.com/
sanger-pathogens/snp-sites. The SNP alignment was used to
build a neighbour-joining tree with the ape package in R.
The SNP alignment was also used to estimate a maximum-
IMPACT STATEMENT
There is growing evidence that patients with Clostridium
difficile-associated diarrhoea often acquire their infecting
strain before hospital admission. To understand potential
environmental reservoirs of C. difficile, we recovered
C. difficile from wastewater treatment plants across a
wide geographical area and used whole genome
sequencing to reveal that strains within each wastewater
treatment plant not only are highly diverse but also that
some are toxigenic. Furthermore, we showed that some
clinical strains are closely related to wastewater iso-
lates. These results demonstrate the clinical significance
of C. difficile in wastewater treatment plants in control-
ling the spread of C. difficile.
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likelihood tree with FastTree 2.1.3 using the generalized
time-reversible model. Phylogenetic trees aligned with the
metadata and geographical data were visualized using
Microreact (www.microreact.org), iTOL [16], FigTree
(www.tree.bio.ed.ac.uk/software/figtree/) and Easyfig [17].
Bayesian analysis
Putative sites of recombination (regions of high SNP den-
sity) were removed using Gubbins [26] with five iterations.
The program BEAST v1.7 [27] was then applied to the SNP
alignment. Various models were tested, including a strict
molecular clock with uniform and lognormal distribution
for base frequency and a General Time Reversible (GTR)
model with a gamma correction for among-size variation.
We executed three independent chains for 50million gener-
ations with sampling every 10 generations and checked the
convergence by considering an effective sample size of
greater than 200, after leaving out the first 50million initial
states as the burn-in phase, using the Tracer software in the
BEAST package. TreeAnnotator software, which is part of the
BEAST package, was then used to merge the simulated tree to
estimate the Bayesian tree. The key parameters such as root
age and substitution rate from different models were in
agreement and therefore the choice of prior model did not
seem to change the results. We presented the results for the
strict clock model.
The likelihood of the ancestral state was estimated for the
presence and absence of toxin genes using the rerootingMe-
thod function (the SYM method) in the phytools package in
R. The tree was visualized using the plotTree function in the
same package.
Antimicrobial resistance determinants, virulence
factors and plasmids
Putative virulence factors and resistance genes were identi-
fied using the srst2 package [28], and a 90% coverage and
similarity cut-off. The virulence factors database was
obtained from (http://www.mgc.ac.cn/VFs/), and the resis-
tance gene database was obtained from the srst2 package.
The genomic regions encoding toxins A and B (PaLoc) and
the binary toxin (CdtLoc) were initially identified using an
in-house in silico PCR tool. The regions were then extracted
and MUMmer [29] was used to map the whole genome
assemblies to the identified genomic regions that contained
the toxin genes. Except for two isolates where srst2 did not
detect the toxin gene correctly, the results of the two meth-
ods were in agreement. Moreover, we ran BLAST on the ele-
ments against the non-redundant nucleotide NCBI database
to annotate the genomic regions surrounding the genomic
loci of toxin genes.
RESULTS
Genomic epidemiology of C. difficile associated with
disease and from wastewater treatment plants
We defined the genomic epidemiology of C. difficile
associated with human disease in our region through a ret-
rospective observational study of 65 consecutive cases of
C. difficile-associated diarrhoea over 8months at the Cam-
bridge University Hospitals NHS Foundation Trust, a 1100-
bed acute hospital in the East of England. Four patients had
more than one episode over the study period (three patients
with two episodes, and one patient with three episodes, i.e.
recurrent infections as defined in the Methods). A total of
70 clinical isolates were analysed. Furthermore, we exam-
ined C. difficile in hospital sewage and municipal wastewater
treatment plants, with a particular focus on treated water
released into the environment. A cross-sectional survey was
conducted of 20 municipal wastewater treatment plants in
the East of England (10 situated immediately downstream
of acute NHS Hospital Trusts and 10 not directly connected
to acute hospital effluent). Paired samples of untreated and
treated wastewater were cultured from each plant. A sample
from the main septic tank at the Cambridge University Hos-
pitals NHS Foundation Trust was also cultured. C. difficile
was isolated from the hospital sewer and from 18 treatment
plants, nine of which did not directly receive hospital waste
(Fig. 1). C. difficile was isolated from treated wastewater at
the point of release onto surface waters (rivers, canals or the
sea) from all 18 plants. A total of 186 colonies (hereafter
termed isolates) were picked from primary wastewater cul-
ture plates and sequenced, with greater emphasis placed on
treated wastewater (135/186, 73%). The median (range)
number of isolates sequenced per treatment plant was 9.8
(1–21), and 97/186 (52%) isolates were from plants in direct
receipt of hospital waste.
Initial analysis based on multilocus STs revealed 19 distinct
STs in the clinical collection and 38 STs in the wastewater
collection (Fig. 2a). Isolate diversity was also observed in the
majority of individual treatment plants, with a median
(range) number of STs per plant of 6.5 (1–13) (Fig. 2a, c).
Comparison of STs in clinical versus wastewater collections
revealed that 13 out of 44 STs were common to both
(Table S1).
Fig. 1. Location of hospital and wastewater treatment plants in the
East of England where C. difficile isolates were recovered. Triangle,
Cambridge University Hospitals NHS Foundation Trust. Wastewater
treatment plans in direct receipt of hospital effluent (circle) or not in
direct receipt of hospital effluent (square).
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C. difficile consists of six different clades termed 1–5 and
C-I, of which clade 2 has been characterized as being associ-
ated with more severe disease (hypervirulent) [30]. A phylo-
genetic analysis based on 112378 SNPs in the core genomes
of the 70 clinical and 186 environmental isolates showed
that our collection lacked isolates belonging to clade 2 (con-
sistent with a previous study of clinical isolates from across
Europe [31]) and clade C-I, but included isolates belonging
to the other major C. difficile clades. The majority of isolates
belonged to clade 1 (231/256), the remainder being distrib-
uted across other clades (4/256 clade 3, 11/256 clade 4 and
10/256 clade 5) [30] (Fig. 2c). Clade 4 was entirely com-
posed of environmental isolates, two of which were assigned
to ST37.
The phylogenetic tree demonstrated extensive mixing
between the two groups (Fig. 2c). Genetic relatedness of the
70 clinical isolates was defined by a pairwise comparison of
core genomes to identify the difference in SNPs between
each pair. Isolates were classified as genetically related if
they were <2 SNPs different, genetically distinct if >10 SNPs
different and indeterminate if 3–10 SNPs different, as previ-
ously described [11]. This analysis showed that 26 isolates
were genetically related to at least one other isolate, five iso-
lates were indeterminate and 39 isolates were genetically
distinct (median 6673 SNPs, range 11–65 104). A phyloge-
netic tree based on SNPs in the core genome of the 70 iso-
lates demonstrated considerable diversity overall (Fig. S1).
Analysis of the genetically related isolates confirmed that
two of four patients with recurrence had infectious episodes
caused by the same strain. Epidemiological analysis of
patients associated with the 26 genetically related isolates
revealed 16 transmission events, of which seven were associ-
ated with direct ward contact, five with indirect ward
Fig. 2. Phylogenetic analysis of C. difficile isolates from patients and wastewater. (a) Multilocus STs for 70 clinical and 186 wastewater
isolates. Clinical isolate STs are shown in a single bar, while wastewater STs are shown according to treatment plant. Each colour
refers to one ST. (b) Pairwise core genome SNP distance for clinical isolates and for isolates from each treatment plant. The total his-
togram shows the pairwise SNP distance for the whole population. Boxes denote the interquartile range and whiskers indicate the
boundary of 1.5 times the interquartile range. The white marker shows the median value. The coloured area is the probability density
of the data at different values. (c) Neighbour-joining phylogenetic tree for 256 isolate genomes and the distribution of clinical and
wastewater isolates. These are labelled by clade, ST, origin, link to hospital waste (only for wastewater isolates) and wastewater
plants. The black bars in the wastewater plants column show the post-treatment isolates. The circle and square signs show
hospital linked and hospital unlinked isolates within wastewater treatment plans, respectively. Each color corresponds to one
plant. The full and empty signs in the same color show the post- and pre-treatment isolates, respectively, for each plant.
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contact and four with hospital-wide contact. These data
confirm that the majority of C. difficile-associated diarrhoea
was unlinked to other active cases in the hospital, suggesting
that the patient had acquired the infecting organism prior
to admission or from unrecognized cases in the hospital.
On pairwise core genome comparison, the most closely
related clinical–wastewater isolate pair differed by 1 SNP for
treatment plants that directly received hospital effluent and
4 SNPs for plants that did not. Within the wastewater col-
lection, we identified 26 pairs of closely related isolates
(<2 SNPs difference) in which each isolate of the pair was
from a different treatment plant (indicative of dissemination
of the same strain), together with 92 pairs of highly similar
isolates (<2 SNPs difference) in which each isolate in the
pair was from the same plant (indicative of multiple colony
picks of the same strain). Isolate relatedness based on place
of origin was identified through a network analysis (Fig. S2).
This relatedness was nested within a context of genetic
diversity, in which the mean pairwise core genome SNP dis-
tance of isolates cultured from 15 individual plants was
largely similar (~20 000 SNPs) to that of the entire clinical
and wastewater collections (Fig. 2b).
ST11 (ribotype 078) has been recovered from animals and
wastewater and recognized over the last decade as a patho-
genic strain associated with community- and hospital-
acquired disease in Europe [10, 18, 32–34]. In light of this,
we used Bayesian analysis to compare the 10 ST11 isolates
in our collection (seven clinical isolates, three wastewater
isolates each from a different plant in receipt of hospital
effluent) with the genomes of 67 ST11 isolates recovered in
the Netherlands from hospitals and pig farms (Table S2),
where transmission between farmers and pigs has been
observed [33]. This demonstrated recent mixing of isolates
in our collection with isolates from animals, as well as
healthy and diseased humans in the Netherlands, with four
clades diverging within the past 20 years (Fig. S3).
Distribution of toxin genes in C. difficile associated
with disease and from wastewater treatment
plants
Having established that wastewater treatment plants in the
East of England release C. difficile into the environment, we
used whole genome sequencing to evaluate the clinical rele-
vance of isolates destined for release. This analysis consid-
ered the presence of genes encoding putative virulence
determinants (primarily toxin genes) and antibiotic resis-
tance determinants.
The detection of toxin A and B production by clinical iso-
lates is integral to our diagnostic pathway (see Methods),
and thus all our clinical isolates were toxigenic; 68 isolates
carried both PaLoc and CdtLoc (tcdA+/tcdB+/cdtA+/cdtB
+) and two isolates carried PaLoc alone (tcdA+/tcdB+/
cdtA /cdtB ). Screening of 186 wastewater isolates showed
that 106 (56%) were tcdA+/tcdB+/cdtA+/cdtB+, 13 (8%)
were tcdA+/tcdB+/cdtA /cdtB , five (2%) were tcdA /
tcdB /cdtA+/cdtB+, two (1%) were tcdA /tcdB+/cdtA /
cdtB  and 60 (32%) were tcdA /tcdB /cdtA /cdtB 
(Fig. 3a). Two ST37 (ribotype 17) genomes contained full-
length tcdB and mutated tcdA genes with a premature stop
codon, which has been associated with outbreaks worldwide
[35–38]. Furthermore, five isolates were tcdA /tcdB /cdtA
+/cdtB+, all of which were ST48 isolated from three waste-
water treatment plants. There was a complete absence of
PaLoc in the five isolate genomes, and no replacement by an
alternative element.
Toxigenic isolates were isolated from all water treatment
plants, including all treated wastewater samples in these
plants (Fig. 3b). The proportion of toxigenic to non-toxi-
genic isolates was comparable for untreated and treated
wastewater, and between plants that directly received hospi-
tal waste versus those that did not (Fig. 3b, c). There was a
strong correlation between phylogeny and the presence of
the PaLoc and CdtLoc (Pearson correlation test: P<10 3).
This is consistent with stable integration into the genome
following acquisition (Figs S4 and S5). We investigated the
ancestral state for the presence of the CDT locus and found
that this was likely to have been present in ancestral strains
(Fig. S5b) and to have been lost from the same genomic
location (Fig. S5a) in non-toxigenic lineages.
Analysis of 78 additional putative virulence genes revealed
that genes in the flagellar operon (implicated in adherence
and linked to toxin production [39]) were over-represented
in clinical isolates (Student’s t-test P<10 3), but no other
genes were over-represented in either clinical or wastewater
isolates (Fig. S6).
Distribution of antibiotic resistance determinants in
C. difficile associated with disease and from
wastewater treatment plants
Screening of all 256 isolates for genes encoding antibiotic
resistance demonstrated these to be present at relatively low
prevalence overall. The two most common were ermB
encoding erythromycin resistance [33 (13%) isolates (seven
clinical, 26 wastewater)] and tetM encoding tetracycline
resistance [18 (7%) isolates (four clinical, 14 wastewater)]
(Fig. S7). The distribution of ermB- and tetM-positive iso-
lates across the whole collection phylogeny indicated that
these genes had been gained on multiple occasions by differ-
ent lineages (Fig. S7).
The mobile genetic elements (MGEs) on which tetM and
ermB resided were investigated. tetM was identified on four
distinct MGEs. The majority of tetM-positive isolates (13/
18, 72%) carried an accessory region (Acc1tet) that shared
99% sequence identity with the C. difficile reference genome
strain M120 (bases 2 171 636-2 185 712), isolated in the UK
in 2007 from a human source [40]. Isolates carrying this ele-
ment belonged to numerous lineages (ST11, ST29, ST35
and ST48), the last containing clinical and wastewater iso-
lates. Two Acc1tet-positive isolates (one wastewater, one
clinical; both ST11) carried an additional tetM accessory
region (Acc2tet) which were also a close match to the
genome of C. difficile strain MG120 (bases 416 096–
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485 371). A further two tetM-positive isolates (both ST54)
carried a transposon that was highly related to Tn6086, and
three isolates (each a different ST) carried a tetM-associated
accessory fragment (Acc3tet), which revealed a partial
match to the Enterococcus faecium Tn6085 transposon.
ermB was also associated with multiple accessory elements,
although a portion of isolates (11/33, 33%, all ST15 and
including clinical and environmental isolates) carried an
MGE that was closely related to the integrative mobile ele-
ment Tn6215, identified previously in C. difficile strain
CD80 [41]. We also identified two additional ermB-carrying
elements that have been reported previously, namely
Tn6194 identified in C. difficile strain CII7 (accession
HG475346) and Tn6218 identified in C. difficile strain Ox42
(accession HG002387). A proportion of isolates belonging
to different STs carried the ermB gene on a small novel
accessory element of around 3.3 kb (Acc4erm). Besides anti-
biotic resistance genes, we identified known mutations in
gyrA (T82I in seven clinical isolates and four wastewater
isolates) and gyrB (S416A in seven clinical and three waste-
water isolates, S366V in nine clinical isolates and one
wastewater isolate, S366A in eight clinical and 11 wastewa-
ter isolates) associated with fluoroquinolone resistance [42,
43].
DISCUSSION
We found that C. difficile was extensively released into surface
environmental waters, which is consistent with an earlier
study across South Wales in which more than 2500 environ-
mental water samples were tested. C. difficile was recovered
from water samples taken from rivers, lakes and the sea [44].
Previous studies have reported that C. difficile survive waste-
water treatment processes and have found ribotypes that were
common to wastewater and clinical isolates [18–20]. However,
ribotyping is known to lack sufficient genomic resolution to
indicate close relatedness [11]. The use of genome sequencing
allowed us to characterize and compare isolates destined for
release into surface waters and isolates associated with human
disease. Our study revealed multiple instances of genetic relat-
edness between wastewater and clinical isolates, providing
strong evidence for high prevalence of C. difficile strains in
Fig. 3. Presence of two C. difficile pathogenicity loci in different sub-populations. PaLoc, pathogenicity locus carrying genes encoding
toxin A and toxin B. CdtLoc, pathogenicity locus carrying genes encoding the CDT binary toxin. Distribution of pathogenicity loci or toxin
A and toxin B genes according to: (a) source, clinical isolates associated with C. difficile-associated diarrhoea, or wastewater from
treatment plants that were or were not linked to hospital waste; (b) individual wastewater treatment plant; and (c) treated and
untreated wastewater.
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treatment plants and overlap between these and clinically rele-
vant strains, indicating transmission between patients and
environmental waters and persistence of some genotypes in
humans and the environment.
Our results suggest that circulation of C. difficile may
include other potential reservoirs such as animal sources.
For instance, the recent emergence of C. difficile ribotype
078 as a cause of diarrhoea in humans and its isolation from
livestock farms in the Netherlands and elsewhere [33, 45]
suggests that this lineage has an animal reservoir in some
settings. The lineage has been increasingly identified as an
emerging type with reported outbreaks in the UK [34, 46].
We isolated C. difficile ST11/ribotype 078 from wastewater
that was genetically related to isolates from Oxford and the
Netherlands, with evidence for genetic divergence over the
last 20 years. This suggests inter-country as well as inter-
host transmission of this important lineage.
The virulence of C. difficile is primarily attributed to toxin A
and toxin B, located in a pathogenicity locus (PaLoc) [47],
and a binary toxin encoded by the CDT locus (CdtLoc),
reported to be associated with more severe disease [48].
Toxigenic C. difficile was extensively represented, with two-
thirds of isolates positive for genes encoding toxin A, toxin
B and a binary toxin encoded by the CDT locus, or genes
for toxins A and B without CDT (56 and 8%, respectively).
Our findings indicate a high prevalence of toxigenic strains
in wastewater and confirm that toxigenic C. difficile, includ-
ing isolates closely related to those causing human disease,
are widely dispersed across the wastewater system and are
released into the environment. Human acquisition of C. dif-
ficile from downstream surface waters may be possible
directly through recreational activities or indirectly through
the use of water for irrigation of crops.
C. difficile carried in the human gut may act as a donor of
genes encoding antibiotic resistance to other bacterial spe-
cies of clinical importance. Furthermore, sewage provides a
milieu in which mobile elements can be transferred within
and between bacterial species. Screening of study isolates for
carriage of genes encoding resistance to commonly used
antibiotics suggested that these were at a relatively low prev-
alence. Further investigation of the genetic context of the
two most frequent resistance genes (tetM and ermB) sug-
gested that each was associated with multiple accessory ele-
ments. Taken together, our findings indicate that resistance
genes were carried by diverse MGEs. However, C. difficile
isolates belonging to the same lineage but derived from dis-
tinct sources (wastewater and clinical) carried the same
antimicrobial resistance-associated MGEs. One explanation
for this is sharing of MGEs related to common ancestry.
A limitation of our study was that recovery of wastewater
isolates post-dated clinical isolates by 1 year. Contempora-
neous data would allow us to infer directionality of trans-
mission between the clinical and environment settings, but
we propose that our findings still hold because the preva-
lence of C. difficile ribotypes was largely unchanged between
2014 and 2015 [C. difficile ribotyping network for England
and Northern Ireland, Biennial report (2013–2015), www.
gov.uk/government/uploads/system/uploads/attachment_
data/file/491253/CDRN_2013-15_Report.pdf].
In conclusion, this study of the reservoirs and sources for
human acquisition of C. difficile demonstrated extensive
release of toxigenic C. difficile into the environment, includ-
ing toxigenic isolates that were highly related to those caus-
ing clinical disease. The proportion of human disease based
on the acquisition of C. difficile carriage from the natural
environment is difficult to estimate, but the genetic similar-
ity between isolates associated with disease and released into
surface waters calls into question whether strategies are
required to improve bacterial control in treated wastewater.
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